Regencell Bioscience Holdings RGC Institutional Ownership

Updated Oct 11, 2026

Regencell Bioscience Holdings Ltd (NASDAQ:RGC) counted 36 institutional investors among its 13F-reported shareholders for the quarter ended June 30, 2026.

• These investors held 0.28% of outstanding shares in Q2 2026, up from 0.13% the quarter before.
• Total holdings of RGC shares rose 117.22% from Q1 2026, and the holder count rose 176.92% from Q2 2025.
• Of these 36 holders, 28 added to their positions, 5 reduced their stakes and 3 left their positions unchanged.
• Institutional investors held 1.4Mn shares of Regencell Bioscience Holdings in total at the end of Q2 2026, up 758.15K from the prior quarter and up 746.23K from a year earlier.
• As of June 30, 2026, the biggest holder of Regencell Bioscience Holdings was Geode Capital Management, LLC with 422.01K shares, or 0.09% of shares outstanding.
• The biggest increases in RGC positions during Q2 2026 came from Legal & General Group PLC (+118.1K shares), Amundi (+38.56K shares), UBS Group AG (+19.32K shares), Geode Capital Management, LLC (+6.44K shares) and Citigroup Inc (+1.83K shares).
• Holders that trimmed the most shares of Regencell Bioscience Holdings in Q2 2026 while keeping a position were Vident Advisory, LLC (-18.39K shares), Morgan Stanley (-15.03K shares), Squarepoint Ops LLC (-4.58K shares), Bank of America Corp (-2.18K shares) and BlackRock, Inc. (-32 shares).
• According to Business Quant data, the leading holders of RGC for Q2 2026 were Geode Capital Management, LLC (422.01K shares), Alyeska Investment Group, L.P. (416.26K shares), Legal & General Group PLC (128K shares), Jane Street Group, LLC (98.35K shares), XTX Topco Ltd (60.06K shares), Amundi (47.16K shares), UBS Group AG (43.21K shares), Quadrature Capital Ltd (41.75K shares), Susquehanna International Group, LLP (23.13K shares) and Squarepoint Ops LLC (22.04K shares).